COLTENE Holding AG (CLHLF)
USD 61.16
(-19.79%)
USD 61.16
(-19.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 30.85 Million | 25.32 Million | 35.63 Million | 39.37 Million | 24.56 Million |
| Net Income | 14.18 Million | 28.11 Million | 34.75 Million | 9.31 Million | 20.68 Million |
| Depreciation & Amortization | 8.13 Million | 7.26 Million | 7.05 Million | 6.81 Million | 6.29 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 222.33 Thousand | 282.28 Thousand | 361.72 Thousand | 381.78 Thousand | 320.37 Thousand |
| Change in working capital | 9.5 Million | -11.67 Million | -3.21 Million | 2.93 Million | -2.74 Million |
| Other non-cash items | -972.75 Thousand | 1.62 Million | -2.95 Million | 20.3 Million | 11.13 Million |
| Investing Cash Flow | -10.16 Million | -8.86 Million | -10.73 Million | -11.89 Million | -13.5 Million |
| Investments in PPE | -10.31 Million | -8.99 Million | -10.85 Million | -10.71 Million | -13.73 Million |
| Acquisitions | 146.09 Thousand | 130.84 Thousand | 119.47 Thousand | -1.18 Million | 159.03 Thousand |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 72.28 Thousand |
| Other Investing Activities | -2.01 Million | 1.00 | 1.00 | -1.00 | 1.00 |
| Financing Cash Flow | -26.05 Million | -17.22 Million | -39.27 Million | -9.14 Million | -8.62 Million |
| Debt repayment | -2.45 Million | -4.47 Million | -19.31 Million | -1.24 Million | -9.57 Million |
| Dividends payments | -23.41 Million | -19.71 Million | -17.92 Million | -8.96 Million | -18.52 Million |
| Common Stock Repurchased | -181.72 Thousand | -381.73 Thousand | -305.81 Thousand | -248.88 Thousand | - |
| Common Stock Issuance | - | - | - | - | 311.87 Thousand |
| Other Financing Activities | -2.07 Million | 4.14 Million | -17.62 Million | 1.1 Million | 312.1 Thousand |
| Accounts receivables | 871.8 Thousand | -1.94 Million | 4.77 Million | 4.4 Million | 2.46 Million |
| Accounts payables | 4.12 Million | -3.96 Million | 4.9 Million | -3.71 Million | 3.69 Million |
| Inventory | 2.33 Million | -3.08 Million | -12.54 Million | 2.46 Million | -4.38 Million |
| Other working capital | 2.17 Million | -2.67 Million | -346.36 Thousand | -216.07 Thousand | -4.52 Million |
| Cash at beginning of period | 26.19 Million | 28.2 Million | 43.52 Million | 23.71 Million | 21.2 Million |
| Cash at end of period | 21.8 Million | 26.19 Million | 28.2 Million | 43.52 Million | 23.71 Million |
| Capital Expenditure | -10.31 Million | -8.99 Million | -10.85 Million | -10.71 Million | -13.73 Million |
| Effect of forex changes on cash | -1.34 Million | -805 Thousand | 368 Thousand | -699 Thousand | -0.33 |
| Net cash flow / Change in cash | -4.38 Million | -2.01 Million | -15.31 Million | 19.8 Million | 2.51 Million |
| Free Cash Flow | 20.53 Million | 16.33 Million | 24.78 Million | 28.66 Million | 10.82 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.79 Million | 5.77 Million | 1.14 Million | 14.18 Million | 1.05 Million | 5.59 Million |
| Depreciation & Amortization | 1.92 Million | 1.91 Million | 1.16 Million | 8.13 Million | 1.07 Million | 1.92 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 111.16 Thousand | 222.33 Thousand | 102.14 Thousand | - |
| Change in working capital | 3.26 Million | 3.25 Million | 303.18 Thousand | 9.5 Million | 278.56 Thousand | 2.24 Million |
| Other non-cash items | -1.82 Million | -1.81 Million | 482.71 Thousand | -972.75 Thousand | 443.52 Thousand | 1.72 Million |
| Investing Cash Flow | -1.5 Million | -1.49 Million | -2.79 Million | -10.16 Million | -2.56 Million | -2.15 Million |
| Investments in PPE | -1.29 Million | -1.28 Million | -2.18 Million | -10.31 Million | -2 Million | -1.78 Million |
| Acquisitions | 56.72 Thousand | - | 121.14 Thousand | 146.09 Thousand | - | 23.45 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -208.16 Thousand | -207.34 Thousand | -611.11 Thousand | -2.01 Million | -561.5 Thousand | -370.94 Thousand |
| Financing Cash Flow | -2.82 Million | -2.81 Million | -2.96 Million | -26.05 Million | -2.72 Million | -9.46 Million |
| Debt repayment | -7.78 Million | - | -5.93 Million | -2.45 Million | - | -3.26 Million |
| Dividends payments | -13.28 Million | -6.62 Million | - | -19.71 Million | - | -11.01 Million |
| Common Stock Repurchased | -68.46 Thousand | -68.19 Thousand | - | -181.72 Thousand | - | -85.47 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 3.89 Million | 3.88 Million | -2.96 Million | -2.07 Million | -2.72 Million | 1.63 Million |
| Accounts receivables | -3.31 Million | - | 1.16 Million | 871.8 Thousand | 1.06 Million | -680.99 Thousand |
| Accounts payables | -129.02 Thousand | - | 2.67 Million | 4.12 Million | - | 1.35 Million |
| Inventory | 1.26 Million | 1.26 Million | 18.42 Thousand | 2.33 Million | 16.93 Thousand | 1.08 Million |
| Other working capital | 2 Million | 1.99 Million | -876.25 Thousand | 2.17 Million | -805.12 Thousand | 1.84 Million |
| Cash at beginning of period | 21.8 Million | - | 26.17 Million | 26.19 Million | - | 26.19 Million |
| Cash at end of period | 5.28 Million | 5.26 Million | 21.8 Million | 21.8 Million | -2.77 Million | 26.17 Million |
| Capital Expenditure | -1.29 Million | -1.28 Million | -2.18 Million | -10.31 Million | -2 Million | -1.78 Million |
| Effect of forex changes on cash | 441.93 Thousand | 440.19 Thousand | -462.5 Thousand | -1.34 Million | -424.95 Thousand | -316.19 Thousand |
| Net cash flow / Change in cash | -16.51 Million | 5.26 Million | -4.36 Million | -4.38 Million | -2.77 Million | -19.26 Thousand |
| Free Cash Flow | 7.87 Million | 7.84 Million | 1.02 Million | 20.53 Million | 940.03 Thousand | 9.71 Million |
WOCKPHARMA
ASBFY
PEB
IKIO
HUHTAMAKI
FCU